Illumina, Inc. (ILMN) stock analysis

In our weekly check, Illumina, Inc. is graded B (A to F). Of 19 checks on debt, profit, cash flow and trend: 15 pass, warnings: 3, red flags: 1.

Sector: Healthcare · Diagnostics & Research

Strengths

• Easily covers interest
• Margins rising
• Profits backed by cash
• Strong free cash flow
• High return on capital

Warning signs

• Weak revenue growth
• Gross margin falling
• Weak EPS growth
• High beta

Next earnings report: 2026-10-29

Similar companies

IDXX · WAT · IQV · A · MTD · NTRA

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis